Thermo Fisher (TMO) announced that it has completed the repurchase of $1B of its common stock. As of December 3, $3B remained available under the company’s share repurchase authorization.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher announces $4B share repurchase program
- Mainz Biomed, Thermo Fisher sign collaboration agreement
- Seer, Thermo Fisher enter co-marketing and sales agreement
- Thermo Fisher price target lowered to $718 from $767 at RBC Capital
- Thermo Fisher price target lowered to $620 from $625 at Bernstein